Join
Search

Posts Tagged ‘Conflict of Interest’

Spring Brings Hope–Even about Transparency and Accountability in Government

There is some good, albeit modest, news about the Food and Drug Administration and the way the agency addresses conflicts of interest on FDA advisory panels that consider the safety and efficacy of drugs and medical devices. Read More

Bookmark and Share

How Disclosure Changed a Conversation on Fracking (And Why that Matters)

Last week, I moderated a session on fracking at the annual fall meeting of the American Geophysical Union (AGU). The event went as we planned with seven speakers presenting their work on unconventional oil and gas development, but after the formal talks when we opened a panel discussion with questions from the audience, something unexpected happened. Read More

Bookmark and Share

Through the Looking Glass: Climate Change Denial, Conflict of Interest and Connecting Science to Policy

The Boston Globe has an outstanding series of articles entitled “Broken City” and it is not hard to guess which city they are referring to.  Hint—not the one that boasts a World-Series-winning team. Read More

Bookmark and Share

Putting the Interests of Patients First: Conference Endorses Science-Focused Health Care

It’s not often that some of the best and most creative minds in medicine, medical ethics and healthcare all gather in one place. It’s even more rare when all these individuals are gathered together to focus on one problem—undue corporate influence on the treatment of patients in the U.S. Read More

Bookmark and Share

Shining A Light On Physician Payments: Delayed Rule Imperfect But Useful

Back in 2010, when Congress approved the Patient Protection and Affordable Care Act, commonly known as “Obamacare,” it included a requirement to help all of us become more knowledgeable about our health care, and to reduce unacceptable conflicts of interest between physicians and drug and device makers. Read More

Bookmark and Share

Compounding The Problem

If you want to see what a world without regulatory safeguards looks like, you don’t have to look far. The current and evolving outbreak of fungal meningitis tied to one large compounding pharmacy in Massachusetts is a case study in what happens when state and federal regulators fail. It also shows what can happen when conflicts of interest get in the way of regulation based on the best available science. Read More

Bookmark and Share